Congratulations to Dr. Eric Lécuyer, who is among those who will receive an ALS Canada - Brain Canada 2024 Discovery Grant. Dr. Lécuyer will receive $125,000 over 2 years for his research project entitled “Studying the involvement of cell surface RNA binding proteins in ALS pathogenesis”, conducted with a team of collaborators, including Drs. Christine Vande Velde and Hideto Takahashi.
Learn more on the research project
Eight high-potential projects will be funded this year to stimulate progress and innovation in amyotrophic lateral sclerosis (ALS) research, as part of the ALS Canada-Brain Canada 2024 Discovery Grants Program, for a total investment of $1,170,000 from the ALS Society of Canada (ALS Canada) and Brain Canada.
The result of a collaboration between ALS Canada and Brain Canada, the Discovery Grants program provides the research community with crucial funding for projects aimed at identifying the causes of ALS, treatments for ALS or related neurological diseases, and helping to maximize function, minimize disability and optimize quality of life for the more than 4,000 Canadians and their loved ones living with ALS.
